Insider Transactions in Q1 2021 at Molina Healthcare, Inc. (MOH)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2021
|
Jeff D. Barlow Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,654
-11.56%
|
$4,363,188
$222.24 P/Share
|
|
Mar 01
2021
|
Jeff D. Barlow Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,542
+13.49%
|
$6,558,324
$222.24 P/Share
|
|
Mar 01
2021
|
Marc Russo EVP, Health Plans |
BUY
Grant, award, or other acquisition
|
Direct |
4,050
+18.24%
|
$899,100
$222.24 P/Share
|
|
Mar 01
2021
|
James Woys Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,361
-7.75%
|
$1,856,142
$222.24 P/Share
|
|
Mar 01
2021
|
James Woys Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,610
+14.49%
|
$4,131,420
$222.24 P/Share
|
|
Mar 01
2021
|
Maurice Hebert Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
930
-8.75%
|
$206,460
$222.24 P/Share
|
|
Mar 01
2021
|
Maurice Hebert Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,926
+21.97%
|
$649,572
$222.24 P/Share
|
|
Mar 01
2021
|
Thomas L Tran |
SELL
Payment of exercise price or tax liability
|
Direct |
11,938
-15.74%
|
$2,650,236
$222.24 P/Share
|
|
Mar 01
2021
|
Thomas L Tran |
BUY
Grant, award, or other acquisition
|
Direct |
28,474
+38.89%
|
$6,321,228
$222.24 P/Share
|
|
Mar 01
2021
|
Joseph M Zubretsky President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
110,141
-23.71%
|
$24,451,302
$222.24 P/Share
|
|
Mar 01
2021
|
Joseph M Zubretsky President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
193,942
+26.56%
|
$43,055,124
$222.24 P/Share
|
|
Mar 01
2021
|
Garrey Carruthers Director |
SELL
Open market or private sale
|
Indirect |
825
-13.75%
|
$183,150
$222.5 P/Share
|
|
Mar 01
2021
|
Mark Lowell Keim Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,039
-16.27%
|
$1,784,658
$222.24 P/Share
|
|
Mar 01
2021
|
Mark Lowell Keim Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,820
+27.49%
|
$4,178,040
$222.24 P/Share
|
|
Feb 22
2021
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
375
-1.98%
|
$82,125
$219.44 P/Share
|
|
Jan 10
2021
|
Mark Lowell Keim Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
889
-3.38%
|
$216,027
$243.1 P/Share
|
|
Jan 01
2021
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
259
+4.05%
|
$54,908
$212.68 P/Share
|
|
Jan 01
2021
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
259
+1.35%
|
$54,908
$212.68 P/Share
|
|
Jan 01
2021
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
259
+5.94%
|
$54,908
$212.68 P/Share
|
|
Jan 01
2021
|
Garrey Carruthers Director |
BUY
Grant, award, or other acquisition
|
Indirect |
259
+4.14%
|
$54,908
$212.68 P/Share
|
|
Jan 01
2021
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
259
+1.82%
|
$54,908
$212.68 P/Share
|
|
Jan 01
2021
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
259
+7.02%
|
$54,908
$212.68 P/Share
|
|
Jan 01
2021
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
259
+1.21%
|
$54,908
$212.68 P/Share
|
|
Jan 01
2021
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
259
+8.39%
|
$54,908
$212.68 P/Share
|